Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

The Key to Early Rheumatoid Arthritis

Annette H.M. van der Helm-van Mil, MD, PhD, and Tom W.J. Huizinga, MD, PhD  |  September 1, 2010

The conundrum of classification versus diagnosis

Filed under:Clinical Criteria/GuidelinesConditionsRheumatoid Arthritis Tagged with:Diagnostic CriteriaGuidelinesRheumatoid arthritisTreatment

TNF Blockade for SLE

Martin Aringer, MD, and Maria Dall’Era, MD  |  September 1, 2010

Reckless approach versus missed opportunity?

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:LupusSLESystemic lupus erythematosusTNF BlockadeTreatmenttumor necrosis factor

Our Commitment to Research

Stanley B. Cohen, MD  |  August 1, 2010

The ACR has a wide range of programs to support investigations in rheumatology

Filed under:ConditionsPresident's PerspectiveResearch RheumRheumatoid Arthritis Tagged with:AC&RBasic researchClinical researchNational Institutes of HealthNIHREF Newsrheumatic diseasesRheumatoid arthritis

ACR and EULAR Debut New RA Classification Criteria in August

Gretchen Henkel  |  August 1, 2010

The complex development process focused on earlier detection and treatment

Filed under:ConditionsRheumatoid Arthritis Tagged with:Classification CriteriaDiagnostic CriteriaGuidelinesRARheumatoid arthritisTreatment

Drug Updates

From the College  |  July 1, 2010

Information on New Approvals and Medication Safety

Filed under:Drug UpdatesFrom the College Tagged with:ApprovalsBiologicsJuvenile arthritisPipline

Coding Corner Question

From the College  |  July 1, 2010

July’s Coding Challenge

Filed under:Billing/CodingFrom the CollegePractice Support Tagged with:BillingCodingInfusionInjectionModifier

Coding Corner Answer

From the College  |  July 1, 2010

July’s Coding Answer

Filed under:Billing/CodingFrom the CollegePractice Support Tagged with:BillingCodingInfusionInjectionModifier

Ethics Forum: Understanding the Challenges in Rheumatology Today

C. Ronald MacKenzie, MD, Elizabeth, Kitsis, MD, MBE, and Michele Meltzer, MD, MBE  |  July 1, 2010

Understand the challenges in rheumatology today

Filed under:EthicsProfessional Topics Tagged with:EthicsHealth InsuranceMethotrexateRheumatoid arthritisrheumatology

Cardiovascular Disease Risk High in RA Patients

Kathy Holliman  |  June 1, 2010

High incidence of metabolic disease and concurrent inflammation increases risk

Filed under:Clinical Criteria/GuidelinesConditionsRheumatoid Arthritis Tagged with:Cardiovascular diseaseinflammationRheumatoid arthritis

Cobra Therapy for Rheumatoid Arthritis

Lilian H.D. van Tuyl, PhD, and Maarten Boers, MD, PhD  |  June 1, 2010

Initial high-dose therapy may help patients seeking relief

Filed under:ConditionsRheumatoid Arthritis Tagged with:Cobra TherapyDisease-modifying antirheumatic drugs (DMARDs)prednisoloneRheumatoid arthritisTreatment

  • « Previous Page
  • 1
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • …
  • 105
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences